RxDoctor Payments Data
★ My doctorsLook up a doctor →

Andrew Watt, MD

Plastic and Reconstructive Surgery · Stanford, CANPI 1356538334

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $42,319 of the $54,693 with a category attached, or 77.4%. Axogen accounts for 96.1% of it on its own, with 35 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,693in general payments, 2019–2025

Across 129 payments — averaging $423.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$53K
  • Integra Lifesciences Corporation$187
  • Access Pro Medical, LLC$175
  • RTI Surgical, Inc$165
  • AbbVie$145
  • Alafair Biosciences, Inc.$141
  • plus $1K from 30 others

What the payments were for

  • Consulting fees$5,57510%
  • Speaking & faculty fees$42,31977%
  • Travel & lodging$2,5895%
  • Food & beverage$4,2108%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axogen54$52,549
Integra Lifesciences Corporation9$187
Access Pro Medical, LLC5$175
RTI Surgical, Inc1$165
AbbVie3$145
Alafair Biosciences, Inc.2$141
Polarityte, Inc.4$117
Orthofix Medical, Inc.4$103
Electronic Waveform Lab, Inc.5$87
Urgo Medical North America, LLC2$84
Derma Sciences, Inc.3$76
Smith+Nephew2$74
Baxter Healthcare2$57
Bioventus LLC2$54
Innovation Technologies Inc3$53
Musculoskeletal Transplant Foundation Inc.2$49
Stryker1$44
Pacira Pharmaceuticals Incorporated2$44
Endo Pharmaceuticals Inc.2$41
Osiris Therapeutics Inc.1$40
Coloplast2$37
Medela LLC2$35
Mimedx Group, Inc.2$35
Checkpoint Surgical, Inc1$34
Vertex1$30
Acell, Inc.1$30
Solventum Corporation1$29
Tactile Systems Technology Inc1$28
Endo USA, Inc.1$24
Acelrx Pharmaceuticals, Inc.1$22
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)1$22
Mallinckrodt Hospital Products Inc.1$18
Acacia Pharma Inc2$18
Polynovo North America LLC1$18
Evolution Surgical, Inc1$16
Molnlycke Health Care US, LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,693 in reported general payments places this provider in the 90th percentile of 349 plastic and reconstructive surgery providers in California.

See all plastic and reconstructive surgery providers in California →

Medicare billing

Part B allowed, 2024
$78,093
Medicare patients
92
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Stanford

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →